Publicaciones en las que colabora con MARÍA DOLORES MORAGUES TOSANTOS (31)

2017

  1. Molecular identification of saprochaete capitata in human blood and paraffinized tissue samples

    Journal of Clinical Microbiology

2015

  1. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases

    Revista Iberoamericana de Micologia, Vol. 32, Núm. 3, pp. 190-196

2014

  1. Candida antigens and immune responses: Implications for a vaccine

    Expert Review of Vaccines, Vol. 13, Núm. 8, pp. 1001-1012

2013

  1. Invasive infections caused by Saprochaete capitata in patients with haematological malignancies: Report of five cases and review of the antifungal therapy

    Revista Iberoamericana de Micologia, Vol. 30, Núm. 4, pp. 248-255

2012

  1. Periodontopathogen and epstein-barr virus contamination affects transplanted bone volume in sinus augmentation

    Journal of Periodontology, Vol. 83, Núm. 2, pp. 162-173

2011

  1. Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 7, pp. 3156-3163

2009

  1. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity

    Journal of Medical Microbiology, Vol. 58, Núm. 11, pp. 1437-1442

2007

  1. Identificación rápida de Candida dubliniensis mediante la prueba Bichro-Dubli®

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 9, pp. 576-578

2006

  1. Diagnostic potential of (1→3)-β-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients

    Revista Iberoamericana de Micologia, Vol. 23, Núm. 4, pp. 209-215

  2. Evaluation of Bichro-Dubli Fumouze® to distinguish Candida dubliniensis from Candida albicans

    Diagnostic Microbiology and Infectious Disease, Vol. 55, Núm. 2, pp. 165-167

  3. Evaluation of the new chromogenic medium candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species

    Journal of Clinical Microbiology, Vol. 44, Núm. 9, pp. 3340-3345

  4. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: Comparison of CLSI M27-A2, Sensitive YeastOne, disk diffusion, and Etest methods

    Microbial Drug Resistance, Vol. 12, Núm. 4, pp. 246-251

  5. Isolation of Issatchenkia occidentalis from the esophagus of a leukemic patient

    Revista Iberoamericana de Micologia, Vol. 23, Núm. 4, pp. 235-237

  6. Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis

    Medical Mycology, Vol. 44, Núm. 7, pp. 611-615

2005

  1. Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico

    Journal of Clinical Microbiology, Vol. 43, Núm. 8, pp. 4159-4162

  2. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons

    Revista Iberoamericana de Micologia, Vol. 22, Núm. 2, pp. 83-92

  3. Supplementation of CHROMagar candida medium with Pal's medium for rapid identification of Candida dubliniensis

    Journal of Clinical Microbiology, Vol. 43, Núm. 11, pp. 5768-5770

2004

  1. Evaluación de una nueva técnica comercializada (Candida albicans IFA IgG) para el diagnóstico de la candidiasis invasiva

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 2, pp. 83-88

  2. Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis

    Diagnostic Microbiology and Infectious Disease, Vol. 50, Núm. 3, pp. 219-221

  3. Is there a role for antibody testing in the diagnosis of invasive candidiasis?

    Revista Iberoamericana de Micologia, Vol. 21, Núm. 1, pp. 10-14